Abiopharma

New Form 6-K - TAKEDA PHARMACEUTICAL CO LTD Filed: 2025-07-02 AccNo: 0001395064-25-000111 Size: 687 KB

New Form 4 - Air Products & Chemicals, Inc. Filed: 2025-07-02 AccNo: 0001225208-25-006272 Size: 5 KB

New Form 4 - Air Products & Chemicals, Inc. Filed: 2025-07-02 AccNo: 0001225208-25-006273 Size: 5 KB

New Form 4 - Air Products & Chemicals, Inc. Filed: 2025-07-02 AccNo: 0001225208-25-006274 Size: 5 KB

New Form 4 - Air Products & Chemicals, Inc. Filed: 2025-07-02 AccNo: 0001225208-25-006275 Size: 5 KB

New Form 6-K - Nanobiotix S.A. Filed: 2025-07-02 AccNo: 0001628280-25-033844 Size: 1 MB

New Form SCHEDULE 13G - Inmune Bio, Inc. Filed: 2025-07-02 AccNo: 0001649553-25-000121 Size: 15 KB

New Form 8-K - Veradigm Inc. Filed: 2025-07-02 AccNo: 0000950170-25-092569 Size: 144 KB Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

New Form 6-K - Inspira Technologies OXY B.H.N. Ltd Filed: 2025-07-02 AccNo: 0001213900-25-060734 Size: 32 KB

New Form 8-K - Sonnet BioTherapeutics Holdings, Inc. Filed: 2025-07-02 AccNo: 0001641172-25-017478 Size: 492 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item …